TREX1 and melanoma: Carboplatin, a second-generation platinum antitumor drug derived from cisplatin, was also recently shown to suppress human melanoma through the activation of cGAS/STING pathway-mediated apoptosis, an effect facilitated through the upregulation of TREX-1 expression in human melanoma (70, 71).